Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, announces its meetings with the investors and shareholders during the second semester 2015.
September 16, 2015 |
11:30am: - Analyst and Investor Meeting
5:30pm: Audio/web conference |
September 22, 2015 |
InvestorDagen
Radisson Blu Scandinavia Hotel - Copenhagen, Denmark |
October 7 & 8, 2015 |
European Large & Midcap Event
Palais Brongiart, Paris |
November 5, 2015 |
Société Générale CIB Healthcare & Biotechnology Conference
Pavillon Ledoyen, Paris |
November 20 & 21, 2015 |
Salon Actionaria
Palais des Congrès, Paris |
November 24, 2015 |
Natixis Small & Mid Caps Conference
Pavillon Gabriel, Paris |
150708EN_Onxeo agenda S2 2015
OnxeoS.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), et innovativt selskab med speciale i udvikling af lægemidler til behandling af sjældne kræftsygdomme, har i dag offentliggjort en oversigt over møder med investorer og aktionærer i 2. halvår 2015.
16. september 2015 |
11.30 - Møde med analytikere og investorer
17.30 - Audio/web-konference |
22. september 2015 |
InvestorDagen
Radisson Blu Scandinavia Hotel - København, Danmark |
7. og 8. oktober 2015 |
European Large & Midcap Event
Palais Brongiart, Paris |
5. november 2015 |
Société Générale CIB Healthcare & Biotechnology Conference
Pavillon Ledoyen, Paris |
20. og 21. november 2015 |
Salon Actionaria
Palais des Congrès, Paris |
24. november 2015 |
Natixis Small & Mid Caps Conference
Pavillon Gabriel, Paris |
150708DK_Onxeo agenda S2 2015
distributed by |